CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY

Aim of the study is to show the pathogenetic importance of myocardial revascularization and to estimate quantitatively effi ciency of the treatment of cardiac allograft vasculopathy after heart transplantation.

Materials and methods. 30 percutaneous coronary interventions (PCI) were performed to recipients of heart transplant (8 men and 7 women, aged from 18 to 56 years), who were diagnosed with cardiac allograft vasculopathy by coronary angiography within the time period from 1,5 to 12 years after heart transplantation. Before revascularization and one week after tolerances to physical activity, volume characteristics of the left ventricle were defi ned and diastolic function of heart was estimated. Average term of observation after stenting was 35,5 ± 5,5 months.

Results. Tolerance to physical activity (from 76,6 ± 8,5 to 116,9 ± 9,6 W), its duration (from 5,4 ± 2,2 to 8,5 ± 4,1 min) and rate pressure product – RPP (from 198 ± 15 to 247 ± 24 P < 0,05) increased. There was a restoration of diastolic function (Ve/Va from 0,57 ± 0,18 to 1,15 ± 0,2 P < 0,05). Signifi cant distinction in time frames of vasculopathy development, frequency and reasons of repeated interventions depending on age of patients is revealed. In the group of patients younger than 30 years of age (7 patients), the time interval between heart transplantation and vasculopathy development is twice shorter, than in more senior patient group, over 45 years old (8 patients). Young patients showed the expressed tendency to develop stent restenosis (20 coronary interventions).

Conclusion. Dynamics in functional condition of the left ventricle as a result of revascularization confi rms the leading role of miocardial ischemia in pathogenesis of transplant insuffi ciency due to vasculopathy. The signifi cant factor infl uencing upon long-term result of coronary intervention is the age of the patient.

1. Казаков ЭН, Кормер АЯ, Честухин ВВ, Голубицкий ВВ. Патология коронарных артерий пересаженного сердца по данным коронарографии. Трансплантология и искусственные органы. 1996. 4: 74–77. Kazakov EN, Kormer AYa, Chestukhin VV, Golubitskiy VV. Patologiya koronarnykh arteriy peresazhennogo serdtsa po dannym koronarografi i. Transplantologiya i iskusstvennye organy. 1996. 4: 74–77.

2. Честухин ВВ, Остроумов ЕН, Тюняева ИЮ, Захаревич ВМ и др. Болезнь коронарных артерий пересаженного сердца. Возможности диагностики и лечения. Очерки клинической трансплантологии / Под ред. С.В. Готье. М., 2009. Chestukhin VV, Ostroumov EN, Tyunyaeva IYu, Zakharevich VM i dr. Bolezn' koronarnykh arteriy peresazhennogo serdtsa. Vozmozhnosti diagnostiki i lecheniya. Ocherki klinicheskoy transplantologii / Pod red. S.V. Gautier. M., 2009.

3. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Heimann NE, Kobashigawa JA et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy–2010. J Heart Lung Transplant. 2010; 29: 717–727.

4. Честухин ВВ, Миронков АБ, Тюняева ИЮ, Рядовой ИГ, Захаревич ВМ, Миронков БЛ. Оценка диастолической дисфункции левого желудочка сердечного трансплантата при развитии его васкулопатии. Вестник трансплантологии и искусственных органов. 2013; 1: 6–11. Chestukhin VV, Mironkov АB, Tyuniaeva IY, Ryadovoy IG, Zakharevich VM, Mironkov BL. Estimation of diastolic dysfunction of the left ventricle at development coronary allograft vasculopathy. Vestnik transplantologii I iskusstvennykh organov = Russian journal of transplantology and artifi cial organs. 2013; 1: 6–11. [English abstract].

5. Gao SZ, Alderman EL, Schroeder JS. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic fi ndings. J Am Coll Cardiol. 1988; 12: 334–340.

6. Агеев ФТ, Овчинников АГ. Давление наполнения левого желудочка: механизмы развития и ультразвуковая оценка. Сердечная недостаточность. 2012; 13,5 (73): 287–309. Ageev FT, Ovchinnikov AG. Davlenie napolneniya levogo zheludochka: mekhanizmy razvitiya i ul'trazvukovaya otsenka. Serdechnaya nedostatochnost'. 2012; 13, 5 (73): 287–309.

7. Tarantini G, Favaretto E, Gardin A, Napodano M, Isabella G, Panfi li M et al. Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes. J Cardiovasc Med (Hagerstown). 2008 Apr; 9 (4): 396–402.

8. Ильинский ИМ, Белецкая ЛВ, Рябоштанова ЕИ, Куприянова АГ, Можейко НП. Патоморфология. Болезнь коронарных артерий пересаженного сердца. М.: МИА, 2008: 74–97. Il'inskiy IM, Beletskaya LV, Ryaboshtanova EI, Kupriyanova AG, Mozheyko NP. Patomorfologiya. Bolezn' koronarnykh arteriy peresazhennogo serdtsa. M.: MIA, 2008: 74–97.

9. Шумаков ВИ, Казаков ЭН, Хубутия МШ, Кормер АЯ, Шумаков ДВ, Козлов ИА и др. Результаты трансплантации сердца при статусе 1А-В и 2 по UNOS у больных с дилятационной кардиомиопатией. Сердечная недостаточность. 2002; 3, 6 (16): 284–285. Shumakov VI, Kazakov EN, Khubutiya MSh, Kormer AYa, Shumakov DV, Kozlov IA i dr. Rezul'taty transplantatsii serdtsa pri statuse 1A-B i 2 po UNOS u bol'nykh s dilyatatsionnoy kardiomiopatiey. Serdechnaya nedostatochnost'. 2002; 3, 6 (16): 284–285.